Research & Development

At APPIDI Healthcare, research and development is at the core of our commitment to improve healthcare outcomes through practical, safe, and scientifically sound solutions. Our R&D division focuses on developing medical technologies that align with current healthcare needs, while ensuring regulatory compliance and ease of integration into existing systems.

To support our growing research efforts, we have recently established a new manufacturing facility equipped with advanced cleanroom infrastructure. The facility includes Grade B manufacturing areas, Class 1000 cleanrooms, and a dedicated in-house laboratory for product development, testing, and validation. This controlled environment ensures sterile conditions for the formulation and assembly of our infection control and diagnostic products.

The R&D facility is designed to support pilot-scale manufacturing, product trials, and continuous quality improvement. With a dedicated team of scientists, engineers, and technical experts, we maintain a focused approach to innovation, backed by structured documentation, clinical insights, and performance-based evaluations.

Our current pipeline includes the following products under various stages of development:

• Cancer Diagnostics – Development of IVD panels for the early detection and monitoring of various cancer types, with an emphasis on accuracy, accessibility, and clinical relevance.
• In-Vitro Diagnostics (IVDs) – A range of IVD solutions for routine and specialized diagnostic applications to support timely and reliable medical decisions.
• Hemodialyzers – Designing dialysis solutions that aim to improve performance efficiency, patient comfort, and affordability.
• Stericare (Vaporized Hydrogen Peroxide Sterilization System) - A low-temperature sterilization system developed for critical healthcare environments, offering safe and efficient disinfection.
• Rapid Diagnostic Kits – Easy-to-use kits under development for health monitoring parameters such as blood glucose, hemoglobin levels, and other routine indicators.
• Ophthalmic Products – Multiple formulations of contact lens cleaning and disinfection solutions aimed at enhancing eye safety and reducing infection risks in lens users.

Through our expanding R&D capabilities, we aim to bring forward practical healthcare solutions that not only meet current standards but also anticipate the evolving needs of the healthcare sector.